Evidence map›Paper›PMID 40983394›Full record

ReviewTranscription

Transcriptional regulation of gene modules in Epstein-Barr virus.

Paul M Lieberman

Abstract readReview
In one paragraph

Review in Transcription. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Paul M LiebermanCenter for Advanced Therapeutics, The Wistar Institute, Philadelphia, PA.ORCID 0000-0002-3935-9921

Funding

Targeting the Epigenetic and Metabolic Control of EBV-Epithelial CancersP01CA269043 · NCI · WISTAR INSTITUTE · PI Italo Tempera · 2023 to 2026
$12.0M
Virus, Vector and Cell Culture CoreP01CA281867 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ERLE S. ROBERTSON · 2023 to 2026
$9.1M
Regulation of Epstein-Barr Virus LatencyR01CA093606 · NCI · WISTAR INSTITUTE · PI LIEBERMAN, PAUL M. · 2002 to 2022
$6.7M
Epigenetic Regulation of Epstein-Barr Virus Latency ProgramsR01DE017336 · NIDCR · WISTAR INSTITUTE · PI PAUL M. LIEBERMAN · 2005 to 2026
$6.5M
Role of TERRA in Telomere Maintenance and Telomere Stress ResponseR01CA140652 · NCI · WISTAR INSTITUTE · PI LIEBERMAN, PAUL M. · 2010 to 2025
$6.0M
Regulation of EBV Latency by Purine Metabolism and SignalingR01AI153508 · NIAID · WISTAR INSTITUTE · PI TEMPERA, ITALO · 2021 to 2025
$2.3M
Oral Defensins Bridge Innate and Adaptive ImmunityR01DE017335 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI SIEG, SCOTT FREDERICK · 2005 to 2007
$678k
Unique Genomic Regions of Y pestis in PathogenesisR21AI053508 · NIAID · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI GARCIA, EMILIO · 2002 to 2003
$529k
NCI NIH HHS P01 CA269043NCI NIH HHS P01 CA281867NCI NIH HHS R01 CA093606NCI NIH HHS R01 CA140652NIAID NIH HHS R01 AI153508NIAID NIH HHS R21 AI053508NIDCR NIH HHS R01 DE017335NIDCR NIH HHS R01 DE017336
6 · The paper itself

Abstract

Epstein-Barr Virus (EBV) establishes life-long latent infection in >90% of adults and is a causal agent for diverse cancers and autoimmune diseases. EBV has a complex life cycle in multiple different tissue types that involve dynamic variations in viral gene expression. These gene expression changes account for the success of the virus in long-term persistence and evading host immune control, as well as its potential for driving cancer evolution and autoimmune disease. Here, we review some of the salient features of EBV gene regulation highlighting the many variations of viral transcription. We review recent advances in our understanding of the factors that bind and regulate EBV gene expression. Based on this diversity of viral transcription patterns, we propose that EBV genome consists of gene modules regulated by local promoter-proximal transcription factor combinations that are further regulated by distal regulatory interactions among the various modules that interact through architectural factors, such as CTCF and cohesion. These modules are likely to represent chromatin architectural domains, and can also interact with host chromosome domains that further regulate viral and host gene expression. We propose that this gene regulatory hierarchy provides EBV with necessary plasticity for viral persistence, as well as a strong potentiator for cancer and autoimmune disease.

Indexed as

Gene Expression Regulation, ViralHerpesvirus 4, HumanTranscription, GeneticEpstein-Barr Virus InfectionsHumansPromoter Regions, GeneticTranscription FactorsTranscription FactorschromatinepigeneticsEpstein-Barr virus (EBV)herpesvirusRNA polymerasetranscription

Identifiers

PMID40983394
PMCPMC12609180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.